Design of N-Benzoxaborole Benzofuran GSK8175—Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor

[Image: see text] We previously described the discovery of GSK5852 (1), a non-nucleoside polymerase (NS5B) inhibitor of hepatitis C virus (HCV), in which an N-benzyl boronic acid was essential for potent antiviral activity. Unfortunately, facile benzylic oxidation resulted in a short plasma half-lif...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, Pek Y., Shotwell, J. Brad, Miller, John, Price, Daniel J., Maynard, Andy, Voitenleitner, Christian, Mathis, Amanda, Williams, Shawn, Pouliot, Jeffrey J., Creech, Katrina, Wang, Feng, Fang, Jing, Zhang, Huichang, Tai, Vincent W.-F., Turner, Elizabeth, Kahler, Kirsten M., Crosby, Renae, Peat, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466479/
https://www.ncbi.nlm.nih.gov/pubmed/30763090
http://dx.doi.org/10.1021/acs.jmedchem.8b01719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466479/
https://www.ncbi.nlm.nih.gov/pubmed/30763090
http://dx.doi.org/10.1021/acs.jmedchem.8b01719

Ejemplares similares